Quotient Limited to Report Continued Progress on the Commercial Scale-Up of MosaiQ™ and Fiscal First Quarter 2018 Financial...
July 21 2017 - 8:00AM
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics
company, today announced that an update on the results of internal
verification and validation studies for the MosaiQ™ system, as well
as financial results for its fiscal first quarter ended June 30,
2017, will be released after market close on Monday, August 7,
2017.
Quotient will host a conference call on Tuesday,
August 8, 2017 at 8:30 a.m. Eastern Time to discuss its fiscal
first quarter 2018 financial results. Participants may access the
call by dialing 1-877-407-0784 in the U.S. or 1-201-689-8560
outside the U.S. The conference call will be webcast live on the
Company's website at www.quotientbd.com.
A replay of this conference call will be
available through August 15 by dialing 1-844-512-2921 in the U.S.
or 1-412-317-6671 outside the U.S. The replay access code is
13667029.
About Quotient Limited
Quotient is a commercial-stage diagnostics company committed to
reducing healthcare costs and improving patient care through the
provision of innovative tests within established markets. With an
initial focus on blood grouping and serological disease screening,
Quotient is developing its proprietary MosaiQ™ technology platform
to offer a breadth of tests that is unmatched by existing
commercially available transfusion diagnostic instrument platforms.
The company's operations are based in Edinburgh, Scotland; Eysins,
Switzerland and Newtown, Pennsylvania.
The Quotient logo and MosaiQ™ are registered trademarks or
trademarks of Quotient Limited and its subsidiaries in various
jurisdictions.
CONTACT:
Christopher Lindop, Chief Financial Officer — christopher.lindop@quotientbd.com; +41 (0)799 61 69 38
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Sep 2023 to Sep 2024